Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Physical Disability, Anxiety and Depression in People with MS: An Internet-Based Survey via the UK MS Register.
Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β
The Incidence and Prevalence of Thyroid Disease Do Not Differ in the Multiple Sclerosis and General Populations: A Validation Study Using Administrative Data.
Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders.
Phonological fluency strategy of switching differentiates relapsing-remitting and secondary progressive multiple sclerosis patients.
Cytomegalovirus ischemic colitis and transverse myelitis in a renal transplant recipient.
Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial.
The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.
Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
Macrophage Migration Inhibitory Factor Potentiates Autoimmune-Mediated Neuroinflammation.
Retinal periphlebitis is associated with multiple sclerosis severity.
Multiple sclerosis is associated with psoriasis. A case-control study.
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.
Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.
HDAC1/2-Dependent P0 Expression Maintains Paranodal and Nodal Integrity Independently of Myelin Stability through Interactions with Neurofascins.
Sequential activation of microglia and astrocyte cytokine expression precedes increased iba-1 or GFAP immunoreactivity following systemic immune challenge.
Dynamic Assessment of Social Cognition in Individuals with Multiple Sclerosis: A Pilot Study.
Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune Encephalomyelitis.
Intrathecal baclofen in multiple sclerosis.
Diagnostic tools for evaluating the impact of Focal Axonal Swellings arising in neurodegenerative diseases and/or traumatic brain injury.
Interferon beta-associated recurrence of painful trigeminal neuropathy attributed to a multiple sclerosis plaque.
The RESTORE trial: What did we learn about multiple sclerosis?
Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?
If I had clinically isolated syndrome with magnetic resonance imaging diagnostic of multiple sclerosis, I would take vitamin D 10,000 IU daily: Yes.
Neurogenic detrusor overactivity: an update on management options.
Pages
« first
‹ previous
…
469
470
471
472
473
474
475
476
477
…
next ›
last »